Human Monocytes Induce a Carcinoma Cell Line to Secrete High Amounts of Nitric Oxide

Journal of Immunology

Volumn 157, Issue 5, 1996, Pages 2109-2115

  Konur, Abdo ^a   Krause, Stefan W ^a   Rehli, Michael ^a   Kreutz, Marina ^a   Andreesen, Reinhard ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DRUG DERIVATIVE; INTERLEUKIN 1; LEUCINE; LEUCINE METHYL ESTER; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOSYNTHESIS; BLADDER TUMOR; CELL CULTURE; COCULTURE; DRUG COMBINATION; GENETICS; HUMAN; IMMUNOLOGY; KIDNEY MEDULLA; MACROPHAGE ACTIVATION; METABOLISM; MONOCYTE; PHYSIOLOGY; SECRETION; SOLUBILITY; TRANSITIONAL CELL CARCINOMA;

ARGININE; CARCINOMA, TRANSITIONAL CELL; COCULTURE TECHNIQUES; DRUG COMBINATIONS; HUMANS; INTERLEUKIN-1; KIDNEY MEDULLA; LEUCINE; MACROPHAGE ACTIVATION; MONOCYTES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; OMEGA-N-METHYLARGININE; SOLUBILITY; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; URINARY BLADDER NEOPLASMS;

EID: 0030240074     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Nathan, C., and Q.-W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915.
2. Xie, Q.-W., H. J. Cho, J. Calaycay, R. A. Mumford, K. M. Swiderek, T. D. Lee, A. Ding, T. Troso, and C. Nathan. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225.
3. Nussler, A. K., M. Di Silvio, T. R. Billiar, R. A. Hoffman, D. A. Geller, R. Selby, J. Madariaga, and R. L. Simmons. 1992. Stimulation of the nitric oxide pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med. 176:261.
4. Geller, D. A., C. J. Lowenstein, R. A. Shapiro, A. K. Nussler, M. Di Silvio, S. C. Wang, D. K. Nakayama, R. L. Simmons, S. H. Snyder, and T. R. Billiar. 1993. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA 90:3491.
5. Palmer, R. M. J., M. S. Hickery, I. G. Charles, S. Moncada, and M. T. Bayliss. 1993. Induction of nitric oxide synthase in human chondrocytes. Biochem. Biophys. Res. Commun. 193:398.
6. Eizirik, D. L., S. Sandler, N. Welsh, M. Cetkovic-Cvrlje, A. Nieman, D. A. Geller, D. G. Pipeleers, K. Bendtzen, and C. Hellerstrom. 1994. Cytokines suppress human islet function irrespective of their effects in nitric oxide generation. J. Clin. Invest. 93:1968.
7. Sherman, P. A., V. E. Laubach, R. R. Bryan, and E. R. Wood. 1993. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry 32:11600.
8. Reiling, N. A., J. Ulmer, M. Duchrow. M. Ernst, H.-D. Flad, and S. Hauschildt. 1994. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur. J. Immunol. 24:1941.
9. Weinberg, J. B., M. A. Misukonis, P. J. Shami, S. N. Mason, D. L. Sauls, W. A. Dittman, E. R. Wood, G. K. Smith, B. McDonald, K. E. Bachus, A. F. Haney, and D. L. Granger. 1995. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86:1184.
10. Zembala, M., M. Siedlar, J. Marcinkiewicz, and J. Pryjma. 1994. Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccaride. Eur. J. Immunol. 24:435.
11. Andreesen, R., W. Brugger, C. Scheibenbogen, M. Kreutz, H.-G. Leser, A. Rehm, and G. W. Löhr. 1990. Surface phenotype analysis of human monocyte to macrophage maturation. J. Leukocyte Biol. 47:490.
12. Stuehr, D. J., and M. A. Marietta. 1985. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 82:7738.
13. Thiele, D. L., M. Kurosaka, and P. E. Lipsky. 1983. Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester. J. Immunol. 131:2282.
14. 15N]nitrate in biological fluids. Anal. Biochem. 126:131
15. Charles, I. G., R. M. Palmer, M. S. Hickery, M. T. Bayliss, A. P. Chubb, V. S. Hall, D. W. Moss, and S. Moncada. 1993. Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocytes. Proc. Natl. Acad. Sci. USA 90:11419.
16. Putz, E. F., and D. N. Männel. 1995. Monocyte activation by tumor cells: a role for carbohydrate structures with CD2. Scand. J. Immunol. 41:77.
17. Schmidt, H. H. H. W., and U. Walter. 1995. NO at work. Cell 78:919
18. Hibbs, J. B., Jr., Z. Vavrin, and R. R. Taintor. 1987. L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138:550.
19. Lowenstein, C. J., C. S. Glatt, D. S. Bredt, and S. H. Snyder. 1992. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl. Acad. Sci. USA 89:6711.
20. Schneemann, M., G. Schoedon, S. Hofer, N. Blau, L. Guerrero, and A. Schaffner. 1993. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167:1358.
21. De Maria, R., M. G. Cifone, R. Trotta, M. R. Rippo, C. Festuccia, A. Santoni, and R. Testi. 1994. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J. Exp. Med. 180:1999.
22. Scheibenbogen, C., and R. Andreesen. 1991. Developmental regulation of the cytokine repertoire in human macrophages: IL-I, IL-6, TNF-alpha, and M-CSF. J. Leukocyte Biol. 50:35.
23. Hasday, J. D., E. M. Shah, and A. P. Lieberman. 1990. Macrophage tumor necrosis factor-α release is induced by contact with some tumor. J. Immunol. 38: 388.
24. Isler, P., E. Vey, J.-H. Zhang, and J.-M. Dayer. 1993. Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1 beta by monocytic cells: a possible role of CD69. Eur. Cytokine Netw. 4:15.
25. van-de-Loosdrecht, A. A., G. J. Ossenkoppele, R. H. Beelen, M. G. Broekhoven, and M. M. Langenhuijsen. 1992. Role of interferon gamma and tumour necrosis factor alpha in monocyte-mediated cytostasis and cytotoxicity against a human histiocytic lymphoma cell line. Cancer Immunol. Immunother. 34:393.
26. Andreesen, R., S. Gadd, W. Brugger, G. W. Löhr, and R. C. Atkins. 1988. Activation of human monocyte-derived macrophages cultured on teflon: response to interferon-γ during terminal maturation in vitro. Immunobiology 177:186.
27. Xie, K., S. Huang, Z. Dong, S. H. Juang, M. Gutman, Q.-W. Xie, C. Nathan, and I. J. Fidler. 1995. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 181:1333.
28. Leibovich, S. J., P. J. Polverini, T. W. Fong, L. A. Harlow, and A. E. Koch. 1994. Production of angiogenic activity by human monocytes requires an L-arginine/ nitric oxide-synthase-dependent effector mechanism. Proc. Natl. Acad. Sci. USA 91:4190.
29. Jenkins, D. C., I. G. Charles, L. L. Thomson, D. W. Moss, L. S. Holmes, S. A. Baylis, P. Rhodes, K. Westmore, P. C. Emson, and S. Moncada. 1995. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA 92:4392.
30. Andrade, S., I. Hart, and P. Piper. 1992. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Br. J. Pharmacol. 107: 1092.
31. Maeda, H., Y. Noguchi, K. Sato, and T. Akaike. 1994. Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn. J. Cancer Res. 85:331.
32. Lejeune, P., P. Lagadeck, N. Onier, D. Pinard, H. Ohshima, and J. Jeannin. 1994. Nitric oxide involvement in tumor-induced immunosuppression. J. Immunol. 152:5077.